This grant supports investigator-initiated clinical trials that aim to reduce the burden of cancer through advances in early detection, screening, prevention, interception, healthcare delivery, quality of life, and survivorship. Applications must meet NIH clinical trial definitions and exclude trials focused on cancer diagnosis or oncologic therapy. Projects should align with the programmatic interests of the NCI Division of Cancer Prevention and the Division of Cancer Control and Population Sciences.
Eligible applicants include a wide range of organizations such as academic institutions, nonprofits, small businesses, tribal governments, state and local governments, and certain federal agencies. Both domestic and some non-domestic entities may apply.
